Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy
- 31 December 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (14) , 2321-2325
- https://doi.org/10.1016/s0959-8049(97)10011-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future researchEuropean Journal Of Cancer, 1994
- Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1994
- Mechanisms of Treatment FailurePublished by Springer Nature ,1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.Journal of Clinical Oncology, 1989
- New Information on Drug Resistance: Implications for the Adjuvant Treatment of Breast CancerPublished by Springer Nature ,1989
- Tamoxifen rechallenge: response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer.Journal of Clinical Oncology, 1987
- Stimulation of breast cancer with estrogens: How much clinical value?European Journal of Cancer and Clinical Oncology, 1987
- Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapyCancer, 1986
- Endocrine Aspects in Adjuvant Therapy for Early Breast CancerPublished by Springer Nature ,1986